Lactobacillus reuteri Strain Combination In Helicobacter pylori Infection

罗伊乳杆菌 医学 胃肠病学 安慰剂 内科学 尿素呼气试验 幽门螺杆菌 益生菌 抗生素 微生物学 幽门螺杆菌感染 细菌 生物 病理 遗传学 替代医学
作者
Ruggiero Francavilla,Lorenzo Polimeno,Antonella Demichina,Giovanni Maurogiovanni,Mariabeatrice Principi,Giuseppe Scaccianoce,Enzo Ierardi,Francesco Russo,Giuseppe Riezzo,Alfredo Di Leo,Luciano Cavallo,A. Francavilla,James Versalovic
出处
期刊:Journal of Clinical Gastroenterology [Lippincott Williams & Wilkins]
卷期号:48 (5): 407-413 被引量:103
标识
DOI:10.1097/mcg.0000000000000007
摘要

The goals of this study were to investigate the role of a new probiotic preparation (Lactobacillus reuteri DSM 17938 and L. reuteri ATCC PTA 6475) in Helicobacter pylori infection.Specific probiotic strains play a role in H. pylori infection for their ability to decrease bacterial load and gastritis, prevent antibiotic-associated side effects, and increase the eradication rate.This is a prospective, double-blind, randomized, placebo-controlled study in a tertiary care setting. A total of 100 H. pylori-positive naive patients received either L. reuteri combination (2×10 Colony Forming Units) or placebo during a 3-phase study (pre-eradication, eradication, and follow-up). All underwent C urea breath test (C-UBT), blood assessments of gastrin-17 (G17), endoscopy, and the Gastrointestinal Symptom Rating Scale. Eradication was confirmed by C-UBT 8 weeks after the completion of therapy.Fifty patients were allocated in each group. During pre-eradication period, C-UBT δ decreased by 13% in L. reuteri combination as compared with a 4% increase in placebo (-13.2±34% vs. 4.3±27%; P<0.03). During eradication, GSRS increased significantly in placebo as compared with L. reuteri combination (6.8±2.9 vs. 4±3.1; P<0.01). Significantly less patients in L. reuteri combination as compared with placebo-reported side effects (40.9% vs. 62.8%; P<0.04). An abnormal G17 value was found in patients receiving placebo as compared with L. reuteri combination (28% vs. 12%; P<0.02). Eradication rate was 75% in L. reuteri combination and 65.9% in placebo (P=NS). L. reuteri combination increased eradication rate by 9.1% (odds ratio: 1.5).L. reuteri combination alone is able to exert an inhibitory effect on H. pylori growth, and when administered with eradication therapy, it determines a significant reduction in antibiotic-associated side effects. Moreover, L. reuteri combination was able to decrease serum G17 levels and to (not significantly) increase the H. pylori-eradication rate.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
fanatic完成签到,获得积分10
2秒前
李爱国应助搞怪孤丝采纳,获得10
2秒前
2秒前
3秒前
3秒前
3秒前
机智夜雪完成签到,获得积分10
4秒前
乐乐应助月月采纳,获得10
4秒前
4秒前
亚琛求文献完成签到,获得积分10
4秒前
lychee发布了新的文献求助10
5秒前
5秒前
5秒前
5秒前
传奇3应助fanatic采纳,获得10
6秒前
冷艳雁丝完成签到,获得积分10
6秒前
陆一发布了新的文献求助10
7秒前
7秒前
8秒前
研友_ZAxj7n发布了新的文献求助10
8秒前
nn发布了新的文献求助10
8秒前
aertom完成签到,获得积分0
9秒前
9秒前
10秒前
10秒前
生如夏花发布了新的文献求助50
10秒前
化工波比发布了新的文献求助10
10秒前
11秒前
houhou完成签到,获得积分10
11秒前
oiu完成签到,获得积分20
11秒前
11秒前
12秒前
13秒前
所所应助123PY采纳,获得30
13秒前
Rain发布了新的文献求助10
13秒前
14秒前
14秒前
arniu2008应助Tony12采纳,获得40
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Chemistry and Physics of Carbon Volume 18 800
The Organometallic Chemistry of the Transition Metals 800
Leading Academic-Practice Partnerships in Nursing and Healthcare: A Paradigm for Change 800
The formation of Australian attitudes towards China, 1918-1941 640
Signals, Systems, and Signal Processing 610
Research Methods for Business: A Skill Building Approach, 9th Edition 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6423862
求助须知:如何正确求助?哪些是违规求助? 8242181
关于积分的说明 17521948
捐赠科研通 5478134
什么是DOI,文献DOI怎么找? 2893535
邀请新用户注册赠送积分活动 1869788
关于科研通互助平台的介绍 1707531